Michelle Peters Wellington announced Thursday that she has joined Vistagen Therapeutics as VP of communications. MM+M’s third ...

As Merck prepares for its blockbuster immunotherapy Keytruda to face generic competition, it’s investing in a new cancer drug from LaNova.

By registering you consent to the collection and use of your information to provide the products and services you have ...

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...

Officials said they began distributing more than 2 million pieces of personal protective equipment in late May, four months ...

If you bring a baby into the Hurley Children’s Center clinic in downtown Flint, Michigan, Mona Hanna will find you. The ...

Vera Therapeutics appointed Amgen and Seagen alum Matt Skelton as EVP of commercial. Frank Lane was appointed SVP and head of ...

BioNTech is investing in a promising space in oncology by acquiring Biotheus’ PD-L1 and VEGF bispecific antibody.